ABCG2 and cancer: Several reports have demonstrated that in addition to inhibiting the drug efflux function of ABCB1 and ABCG2, the transient down-regulation of these transporters is one of the common alternative mechanisms in which the multidrug-resistant cancer cells can be re-sensitized to chemotherapy [23,47,48].